Researchers found higher consumption of several common sweeteners was associated with faster cognitive decline over time.

Sanofi SNY announced that it is discontinuing the phase III MOBILIZE study, which is evaluating its investigational drug, riliprubart, in patients with chronic inflammatory demyelinating ...

A growing number of U.S. adults—particularly those under 40—are reporting serious challenges with memory, concentration and decision-making, according to a new study published in Neurology.

Researchers have found teaching artistic observation to neurology residents contributed to the development of well-rounded physicians with the capacity to be both skilled clinicians and compassionate ...

For new neurology patients, seeing a physician in person or virtually made no difference in how soon they needed care next, according to an April 22 study in Neurology. The researchers used EHR data ...